Schuyler Kevin bought ADIL

April 7, 2026 · Form 4 insider transaction

Schuyler Kevin bought 9,185 shares of Adial Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
9,185
Price
$0.00
Total value
N/A
Role
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 7, 2026
Filing dateApril 9, 2026
Shares owned after9,213
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents a grant of restricted shares of common stock that vest in full on the earlier of (i) the one-year anniversary of the grant date; or (ii) a Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended), subject to the Reporting Person's continued service to the Issuer through the vesting date.

View the original Form 4 on SEC EDGAR